Efficacy of a health and wellness coaching program for the prevention of cardiovascular disease and stroke in New Zealand adults

Not Applicable

Active, not recruiting

• Conditions: Stroke; Cardiovascular Disease; Cardiovascular - Coronary heart disease; Stroke - Ischaemic; Stroke - Haemorrhagic

• Registration Number: ACTRN12616000379415
• Lead Sponsor: Otago University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 320

Inclusion Criteria

Participants will include 320 adults : minimum age range will be 35 years old for Maori and Pasifika due to earlier age of stroke in these ethnic groups; older than 45 years old for other ethnic groups) with absolute 5-year CVD risk of higher than 10%. The participants will be identified through GP practices that use PREDICT or a similar tool for CVD risk calculation. Must be able to converse in english, have not had a previous stroke or heart attack. There is no upper age limit. Information we have received from the PHO's indicates that most people who are at moderate to high risk are around the 35 to 60 year age bracket.

Exclusion Criteria

Individuals will be excluded if they: (a) is unable to converse in English (b) had previous stroke or heart attack; (c) have significant impairments or medical conditions precluding participation; (d) cannot give informed consent; (e) deemed inappropriate for the intervention by the participant’s GP; (f) receiving treatment that can contaminate the study intervention; or (g) are likely to move out of the study area during the year (h) have clinical depression and/or anxiety as assessed by a screening tool.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of baseline moderate (10-15%) 5 year CVD risk participants with a relative risk reduction of 25% following the intervention, assessed by PREDICT score from primary health care group data. [This will be assessed through the GP at the 9 month time-point]